BORGHI, ELISA
BORGHI, ELISA
Dipartimento di Scienze della Salute
The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review
2026 A. Malgesini, M.D. Marsiglia, E. Borghi, A.V. Marzano, G. Nazzaro
Identification of ICAM-1–targeting DNA aptamers as a host-directed strategy to inhibit Human Rhinovirus infection
2026 J. Dellavedova, C. Campera, S. Ancona, M. Rebecchi, V. Panzeri, T. Carzaniga, L. Casiraghi, S. Rocca, S. Di Ciolo, A. Pedretti, C. Tirelli, M. Buscaglia, T. Bellini, A. Romanelli, A. Villa, E. Brunialti, E. Borghi, P. Ciana
Incidence, risk factors and outcomes of healthcare-associated bacterial infections in COVID-19 patients receiving respiratory support: a retrospective cohort study
2025 M. Augello, R. Castoldi, A. Tavelli, R. Nardo, V. Sala, L. Albertini, L.B. Lundgren, S. De Benedittis, E. Borghi, O. Viganò, G. Marchetti
Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study
2025 M. Tosi, M.D. Marsiglia, E. Ottaviano, S. Parolisi, J. Zuvadelli, S. Ancona, C. Ceccarani, M. Teresa Carbone, G. Cefalo, E. Borghi, E. Verduci
Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial
2025 F. Triva, E. Borghi, M.D. Marsiglia, E. Ottaviano, E. Ricci, P. Tognini, M. Montecucco, A. Vignoli
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms
2025 R. Rovito, V. Bono, N. Coianiz, V. Cazzetta, S. Franzese, J. Mikulak, C. Di Vito, F. Bai, G. Beaudoin-Bussières, A. Tauzin, M. Augello, C. Tincati, A. Santoro, E. Borghi, S. Marozin, A. Finzi, S. della Bella, D. Mavilio, G. Marchetti
Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection
2025 M. Scavone, R. Rovito, C. Ghali, A. Fioretti, B. Clerici, E. Bossi, C. Tincati, A. Santoro, E. Borghi, G. Podda, G.C. Marchetti
Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content
2025 E. Ottaviano, M.V. Dei Cas, S. Ancona, F. Triva, S. Casati, F. Sisto, E. Borghi
Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients
2025 M.D. Marsiglia, S. Bianchi, F. Bai, C. Tincati, E. Ottaviano, S. Ancona, G. Marchetti, E. Borghi
Tuberous sclerosis complex, epilepsy, and the microbiota-gut-brain axis: a pilot study of shared and divergent microbial signatures
2025 E. Ottaviano, M.D. Marsiglia, C. Ceccarani, S. Ancona, F. Triva, F. La Briola, S. Bergamoni, F. Teutonico, A. Pompili, I. Viganò, E. Ricci, A. Vignoli, E. Borghi
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection
2025 S. Marozin, V. Bono, M. Mazzoccoli, M. Augello, R. Rovito, L. Taramasso, A. Di Biagio, A. Callegaro, F. Maggiolo, E. Borghi, C. Tincati, G. Marchetti
Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study)
2024 C. Lammi, E. Ottaviano, G. Fiore, C. Bollati, L. D'Adduzio, M. Fanzaga, C. Ceccarani, S. Vizzuso, G. Zuccotti, E. Borghi, E. Verduci
Gut microbiota profile in CDKL5 deficiency disorder patients
2024 E. Borghi, O. Xynomilakis, E. Ottaviano, C. Ceccarani, I. Viganò, P. Tognini, A. Vignoli
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV
2024 M. Augello, V. Bono, R. Rovito, C. Tincati, S. Bianchi, L. Taramasso, A. Di Biagio, A. Callegaro, F. Maggiolo, E. Borghi, A.D. Monforte, G. Marchetti
Long-Term Effects of SARS-CoV-2 Infection in Hospitalized Children: Findings from an Italian Single-Center Study
2024 V. Calcaterra, V.M. Tagi, E. D'Auria, A. Lai, S. Zanelli, C. Montanari, E. Maria Biganzoli, G. Marano, E. Borghi, V. Massa, A. Riva, G. Zuccotti
Aspetti cognitivi e comportamentali negli errori congeniti del metabolismo: possibile influenza del microbiota-gut-brain axis e ruolo del triptofano
2023 C. Montanari, S. Parolisi, E. Borghi, C. Cazzorla, J. Zuvadelli, M. Tosi, R. Barone, G. Bensi, C. Bonfanti, C. Dionisi Vici, G. Biasucci, A. Burlina, M.T. Carbone, E. Verduci
Preschool-located influenza vaccination and influenza-like illness surveillance: an Italian pilot experience
2023 A. Amendola, E. Borghi, S. Bianchi, M. Gori, C. Fappani, L. Barcellini, F. Forlanini, N. Garancini, C. Nava, A. Mari, A. Sala, C. Gasparini, E. Ottaviano, D. Colzani, E.M. Biganzoli, E. Tanzi, G.V. Zuccotti
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections - That is the question! The opinion of the ESGB board
2023 N. Høiby, C. Moser, A. Oliver, C. Williams, G. Ramage, E. Borghi, J. Azeredo, M.D. Macia
Synthesis of amphiphilic hydantoin-based universal peptidomimetics as antibiotic agents
2023 A.M. Caramiello, M.C. Bellucci, E. Ottaviano, S. Ancona, E. Borghi, A. Volonterio
Our current clinical understanding of Candida biofilms: where are we two decades on?
2023 G. Ramage, E. Borghi, C.F. Rodrigues, R. Kean, C. Williams, J. Lopez-Ribot